These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 2906068)

  • 1. The natural history of tardive dyskinesia.
    Gardos G; Cole JO; Haskell D; Marby D; Paine SS; Moore P
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):31S-37S. PubMed ID: 2906068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone in the treatment of tardive dyskinesia.
    Moss LE; Neppe VM; Drevets WC
    J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early course of new-onset tardive dyskinesia in older patients.
    Lacro JP; Gilbert PL; Paulsen JS; Fell R; Bailey A; Juels C; Caligiuri M; McAdams LA; Harris MJ; Jeste DV
    Psychopharmacol Bull; 1994; 30(2):187-91. PubMed ID: 7831454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.
    Glazer WM; Morgenstern H; Doucette JT
    J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
    Ghadirian AM; Annable L; Bélanger MC; Chouinard G
    J Clin Psychiatry; 1996 Jan; 57(1):22-8. PubMed ID: 8543543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year follow-up study of tardive dyskinesia.
    Gardos G; Cole JO; Perenyi A; Casey DE; Samu I; Kallos M; Schniebolk S
    Adv Biochem Psychopharmacol; 1985; 40():37-42. PubMed ID: 2862767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia.
    Pourcher E; Cohen H; Cohen D; Baruch P; Bouchard RH
    Brain Cogn; 1993 Sep; 23(1):81-7. PubMed ID: 8105825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia and diabetes mellitus.
    Ganzini L; Casey DE; Hoffman WF; Heintz RT
    Psychopharmacol Bull; 1992; 28(3):281-6. PubMed ID: 1362276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affective disorders and tardive dyskinesia.
    Casey DE
    Encephale; 1988 Sep; 14 Spec No():221-6. PubMed ID: 2905650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality.
    Modestin J; Vogt Wehrli M; Stephan PL; Agarwalla P
    Pharmacopsychiatry; 2009 Mar; 42(2):57-60. PubMed ID: 19308879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia.
    Damier P; Thobois S; Witjas T; Cuny E; Derost P; Raoul S; Mertens P; Peragut JC; Lemaire JJ; Burbaud P; Nguyen JM; Llorca PM; Rascol O;
    Arch Gen Psychiatry; 2007 Feb; 64(2):170-6. PubMed ID: 17283284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of tardive dyskinesia development: preliminary results.
    Kane JM; Woerner M; Weinhold P; Wegner J; Kinon B
    J Clin Psychopharmacol; 1982 Oct; 2(5):345-9. PubMed ID: 6127353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in negative symptoms and the risk of tardive dyskinesia: a longitudinal study. UK700 Group.
    van Os J; Walsh E; van Horn E; Tattan T; Bale R; Thompson SG
    Acta Psychiatr Scand; 2000 Apr; 101(4):300-6. PubMed ID: 10782550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Handedness and the risk of tardive dyskinesia.
    Morgenstern H; Glazer WM; Doucette JT
    Biol Psychiatry; 1996 Jul; 40(1):35-42. PubMed ID: 8780853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE; Brown WL; Weigel RM; Casey DE
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance abuse as a risk factor for tardive dyskinesia: a retrospective analysis of 1,027 patients.
    Bailey LG; Maxwell S; Brandabur MM
    Psychopharmacol Bull; 1997; 33(1):177-81. PubMed ID: 9133772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 4():15-20. PubMed ID: 10739326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S; Sandmann U; Genz A
    Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten year outcome of tardive dyskinesia during continuous treatment with first generation antipsychotics.
    Rittmannsberger H
    Psychiatr Danub; 2008 Dec; 20(4):461-5. PubMed ID: 19011586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does clozapine cause tardive dyskinesia?
    Kane JM; Woerner MG; Pollack S; Safferman AZ; Lieberman JA
    J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.